4-(n,n-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole has been researched along with Diabetes Mellitus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Wadood, HM; Ali, MF; Imazato, T; Kishikawa, N; Kuroda, N; Mahmoud, AM; Mohamed, HA; Ohyama, K; Ueki, Y; Wada, M | 1 |
1 other study(ies) available for 4-(n,n-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole and Diabetes Mellitus
| Article | Year |
|---|---|
Chromatographic determination of low-molecular mass unsaturated aliphatic aldehydes with peroxyoxalate chemiluminescence detection after fluorescence labeling with 4-(N,N-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole.
Topics: Adult; Aged; Aged, 80 and over; Aldehydes; Arthritis, Rheumatoid; Chromatography, High Pressure Liquid; Diabetes Mellitus; Female; Fluorescent Dyes; Humans; Lipid Peroxidation; Male; Middle Aged; Molecular Weight; Oxadiazoles; Oxidative Stress; Reproducibility of Results; Spectrometry, Fluorescence; Sulfonamides | 2014 |